Epitomics, Inc.

Abcam is a leading life sciences company providing over 110,000 biological research products and reagents to approximately 750,000 researchers across 130+ countries. The company specializes in primary and secondary antibodies, recombinant antibodies (37,000+ offerings, including 4,900 knockout-validated variants), immunoassays, ELISA kits, proteins, peptides, gene-edited cell lines, and cellular activity assays. Abcam's product portfolio supports critical research in cancer, neurological disorders, infectious diseases, and metabolic disorders. The company is known for data-rich technical specifications, validation data, and high-citation rates among peer researchers. Abcam pioneered e-commerce and data-sharing platforms in life sciences, streamlining antibody and reagent sourcing for academic and pharmaceutical research. Recent innovations include SimpleStep Ignite™ ELISA kits offering 50x greater sensitivity, MollAI AI-powered product recommendation tools, and trial-size antibody offerings to reduce research costs and validation risk.